These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20506560)

  • 1. Deletions of SCN1A 5' genomic region with promoter activity in Dravet syndrome.
    Nakayama T; Ogiwara I; Ito K; Kaneda M; Mazaki E; Osaka H; Ohtani H; Inoue Y; Fujiwara T; Uematsu M; Haginoya K; Tsuchiya S; Yamakawa K
    Hum Mutat; 2010 Jul; 31(7):820-9. PubMed ID: 20506560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental mosaicism in another case of Dravet syndrome caused by a novel SCN1A deletion: a case report.
    Sharkia R; Hengel H; Schöls L; Athamna M; Bauer P; Mahajnah M
    J Med Case Rep; 2016 Mar; 10():67. PubMed ID: 27021235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain expression profiles of two
    Schneider MF; Vogt M; Scheuermann J; Müller V; Fischer-Hentrich AHL; Kremer T; Lugert S; Metzger F; Kudernatsch M; Kluger G; Hartlieb T; Noachtar S; Vollmar C; Kunz M; Tonn JC; Coras R; Blümcke I; Pace C; Heinen F; Klein C; Potschka H; Borggraefe I
    Transl Neurosci; 2024 Jan; 15(1):20220330. PubMed ID: 38283997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expecting the Unexpected: Lack of In Vivo Network Defects in an
    Hull JM; Isom LL
    Epilepsy Curr; 2016; 16(6):408-410. PubMed ID: 27857626
    [No Abstract]   [Full Text] [Related]  

  • 5. An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations.
    Brind'Amour J; Liu S; Hudson M; Chen C; Karimi MM; Lorincz MC
    Nat Commun; 2015 Jan; 6():6033. PubMed ID: 25607992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.
    Han S; Tai C; Westenbroek RE; Yu FH; Cheah CS; Potter GB; Rubenstein JL; Scheuer T; de la Iglesia HO; Catterall WA
    Nature; 2012 Sep; 489(7416):385-90. PubMed ID: 22914087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice.
    Yamagata T; Raveau M; Kobayashi K; Miyamoto H; Tatsukawa T; Ogiwara I; Itohara S; Hensch TK; Yamakawa K
    Neurobiol Dis; 2020 Jul; 141():104954. PubMed ID: 32445790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies.
    Carvill GL; Engel KL; Ramamurthy A; Cochran JN; Roovers J; Stamberger H; Lim N; Schneider AL; Hollingsworth G; Holder DH; Regan BM; Lawlor J; Lagae L; Ceulemans B; Bebin EM; Nguyen J; ; Barsh GS; Weckhuysen S; Meisler M; Berkovic SF; De Jonghe P; Scheffer IE; Myers RM; Cooper GM; Mefford HC
    Am J Hum Genet; 2018 Dec; 103(6):1022-1029. PubMed ID: 30526861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Point Mutation in SCN1A 5' Genomic Region Decreases the Promoter Activity and Is Associated with Mild Epilepsy and Seizure Aggravation Induced by Antiepileptic Drug.
    Gao QW; Hua LD; Wang J; Fan CX; Deng WY; Li B; Bian WJ; Shao CX; He N; Zhou P; Liao WP; Shi YW
    Mol Neurobiol; 2017 May; 54(4):2428-2434. PubMed ID: 26969601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of the human sodium channel SCN1A gene is repressed by a scaffolding protein RACK1.
    Dong ZF; Tang LJ; Deng GF; Zeng T; Liu SJ; Wan RP; Liu T; Zhao QH; Yi YH; Liao WP; Long YS
    Mol Neurobiol; 2014 Oct; 50(2):438-48. PubMed ID: 24436055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
    Ricobaraza A; Bunuales M; Gonzalez-Aparicio M; Fadila S; Rubinstein M; Vides-Urrestarazu I; Banderas J; Sola-Sevilla N; Sanchez-Carpintero R; Lanciego JL; Roda E; Honrubia A; Arnaiz P; Hernandez-Alcoceba R
    J Mol Med (Berl); 2023 Dec; 101(12):1587-1601. PubMed ID: 37819378
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yamagata T; Ogiwara I; Tatsukawa T; Suzuki T; Otsuka Y; Imaeda N; Mazaki E; Inoue I; Tokonami N; Hibi Y; Itohara S; Yamakawa K
    Elife; 2023 May; 12():. PubMed ID: 37219072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCN1A: bioinformatically informed revised boundaries for promoter and enhancer regions.
    Pagni S; Custodio HM; Frankish A; Mudge JM; Mills JD; Sisodiya SM
    Hum Mol Genet; 2023 May; 32(10):1753-1763. PubMed ID: 36715146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient with Dravet syndrome: A case report.
    Yadav R; Shah S; Bhandari B; Marasini K; Mandal P; Murarka H; Pandey AK; Sharma Paudel B
    Clin Case Rep; 2022 May; 10(5):e05840. PubMed ID: 35540719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding regulatory elements: Potential roles in disease and the case of epilepsy.
    Pagni S; Mills JD; Frankish A; Mudge JM; Sisodiya SM
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12775. PubMed ID: 34820881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel functional testing identifies enhancers active in early postnatal mouse brain.
    Lambert JT; Su-Feher L; Cichewicz K; Warren TL; Zdilar I; Wang Y; Lim KJ; Haigh JL; Morse SJ; Canales CP; Stradleigh TW; Castillo Palacios E; Haghani V; Moss SD; Parolini H; Quintero D; Shrestha D; Vogt D; Byrne LC; Nord AS
    Elife; 2021 Oct; 10():. PubMed ID: 34605404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of a non-canonical regulatory sequence causes loss of Scn1a expression and epileptic phenotypes in mice.
    Haigh JL; Adhikari A; Copping NA; Stradleigh T; Wade AA; Catta-Preta R; Su-Feher L; Zdilar I; Morse S; Fenton TA; Nguyen A; Quintero D; Agezew S; Sramek M; Kreun EJ; Carter J; Gompers A; Lambert JT; Canales CP; Pennacchio LA; Visel A; Dickel DE; Silverman JL; Nord AS
    Genome Med; 2021 Apr; 13(1):69. PubMed ID: 33910599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polymicrogyria-associated GPR56 promoter preferentially drives gene expression in developing GABAergic neurons in common marmosets.
    Murayama AY; Kuwako KI; Okahara J; Bae BI; Okuno M; Mashiko H; Shimogori T; Walsh CA; Sasaki E; Okano H
    Sci Rep; 2020 Dec; 10(1):21516. PubMed ID: 33299078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional Regulation of Channelopathies in Genetic and Acquired Epilepsies.
    van Loo KMJ; Becker AJ
    Front Cell Neurosci; 2019; 13():587. PubMed ID: 31992970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.
    Colasante G; Lignani G; Brusco S; Di Berardino C; Carpenter J; Giannelli S; Valassina N; Bido S; Ricci R; Castoldi V; Marenna S; Church T; Massimino L; Morabito G; Benfenati F; Schorge S; Leocani L; Kullmann DM; Broccoli V
    Mol Ther; 2020 Jan; 28(1):235-253. PubMed ID: 31607539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.